Developing a clinical-radiomic prediction model for 3-year cancer-specific survival in lung cancer patients treated with stereotactic body radiation therapy
ConclusionA clinical-radiomic model was developed to predict the 3-year CSS for lung cancer patients treated with SBRT.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Lung Cancer | Radiation Therapy | Study | Training | Universities & Medical Training